August 25, 2008 - CMS Inc., an Elekta Company, has received FDA 510(k) clearance for its new Atlas-Based Autosegmentation (ABAS) solution, designed to reduce the amount of time spent creating and editing patient contours.
The solution produces an estimate of the anatomy boundary contours needed to create a radiation treatment plan. The product is compatible with any radiation treatment planning system that can read standard DICOM RT structure set files. It also provides algorithms for head, neck and prostate treatments in addition to a general algorithm that allows it to be used with other treatment sites.
The ABAS algorithms were developed by Dr. Xiao Han, CMS Research Scientist. Dr. Han's work, titled, "Atlas-based Auto-segmentation of Head and Neck CT Images," will be presented September 9 at the 11th Annual International Conference on Medical Image Computing and Comp.
This clearance allows CMS to immediately begin distributing Atlas-Based Autosegmentation for clinical use in the U.S.
For more information: www.cmsrtp.com